Effect of Botulinum Toxin on Resting Tremor of the Refractory Upper Limb in Parkinsonians
NCT07822893
Basal Ganglia Diseases, Brain Diseases
Nîmes, France
View Trial DetailsNCT Number: NCT07833150
This observational study aims to examine the relationship between performance-based balance test results and quality of life in individuals with Parkinson's disease. It also seeks to determine which balance test best explains quality of life in this population.
Balance and functional performance will be assessed using the Six Spot Step Test, 30-Second Chair Stand Test, Timed Up and Go Test, Four Square Step Test, Berg Balance Scale, and 3-Meter Backward Walk Test. Quality of life will be evaluated using the 39-item Parkinson's Disease Questionnaire (PDQ-39). The findings may help clinicians select appropriate assessment methods and develop rehabilitation programs that address the factors associated with quality of life in individuals with Parkinson's disease.
Trial opening soon.
Get Notified20 year–80 year
All sexes
Observational
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: During the single assessment session (approximately 25 minutes)
Health-related quality of life in individuals with Parkinson's disease will be assessed using the 39-item Parkinson's Disease Questionnaire (PDQ-39). The PDQ-39 Summary Index ranges from 0 to 100, with higher scores indicating poorer health-related quality of life.
Contact information is provided by the study sponsor or research team.
Borna FARHOOMAND, MSc
CONTACT
Büşra ÖZCAN, MSc
CONTACT
Pamukkale University
Other
The Relationship Between Performance-Based Balance Tests and Quality of Life in Individuals With Parkinson's Disease
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07822893
Basal Ganglia Diseases, Brain Diseases
Nîmes, France
View Trial DetailsNCT07832461
Basal Ganglia Diseases, Brain Diseases
Paris, France
View Trial DetailsNCT07815964
Basal Ganglia Diseases, Brain Diseases
Istanbul, Turkey, Turkey (Türkiye)
View Trial DetailsNCT07817862
Basal Ganglia Diseases, Brain Diseases
Istanbul, Fatih, Turkey (Türkiye)
View Trial Details